{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:07:09Z","timestamp":1785935229816,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00063-019-00618-6","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T08:02:31Z","timestamp":1568880151000},"page":"665-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatische Dysfunktion bei Patienten mit kardiogenem Schock","Hepatic dysfunction in patients with cardiogenic shock"],"prefix":"10.1007","volume":"114","author":[{"given":"Philipp","family":"Kasper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Michael","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1055\/s-0033-1349457","volume":"138","author":"H Thiele","year":"2013","unstructured":"Thiele\u00a0H (2013) Treatment of cardiogenic shock: what is proven? Dtsch med Wochenschr 138:1960\u20131965","journal-title":"Dtsch med Wochenschr"},{"key":"618_CR2","unstructured":"Revidierte S3-Leitlinie \u2013 Infarktbedingter kardiogener Schock \u2013 Diagnose, Monitoring und Therapie. (Revision noch nicht abgeschlossen)"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.jacc.2019.01.053","volume":"73","author":"S Vallabhajosyula","year":"2019","unstructured":"Vallabhajosyula\u00a0S, Dunlay\u00a0S, Prasad\u00a0A et\u00a0al (2019) Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock. J\u00a0Am Coll Cardiol 73:1981\u20131791","journal-title":"J Am Coll Cardiol"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ejhf.872","volume":"19","author":"V Harjola","year":"2017","unstructured":"Harjola\u00a0V, Mullens\u00a0W, Banaszewski\u00a0M et\u00a0al (2017) Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 19:821\u2013836","journal-title":"Eur. J. Heart Fail."},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"e0206655","DOI":"10.1371\/journal.pone.0206655","volume":"13","author":"E Iesu","year":"2018","unstructured":"Iesu\u00a0E, Franchi\u00a0F, Zama Cavicchi\u00a0F et\u00a0al (2018) Acute liver dysfunction after cardiac arrest. PLoS ONE 13:e206655","journal-title":"PLoS ONE"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.resuscitation.2016.03.021","volume":"103","author":"B Champigneulle","year":"2016","unstructured":"Champigneulle\u00a0B, Geri\u00a0G, Bougouin\u00a0W et al (2016) Hypoxic hepatitis after out-of-hospital cardiac arrest: Incidence, determinants and prognosis. Resuscitation 103:60\u201365","journal-title":"Resuscitation"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00063-013-0287-2","volume":"108","author":"A Koch","year":"2013","unstructured":"Koch\u00a0A, Streetz\u00a0K, Tischendorf\u00a0J et\u00a0al (2013) Abnormal liver function tests in the intensive care unit. Med Klin Intensivmed Notfmed 108:599\u2013608","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad\u00a0P, Tacke\u00a0F, Koch\u00a0A, Trautwein\u00a0C (2017) Liver\u2014guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol 14:55\u201366","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/j.1478-3231.2011.02655.x","volume":"32","author":"J Henrion","year":"2012","unstructured":"Henrion\u00a0J (2012) Hypoxic hepatitis. Liver Int 32:1039\u20131052","journal-title":"Liver Int"},{"key":"618_CR10","first-page":"1","volume":"5","author":"C de Tymowski","year":"2019","unstructured":"de Tymowski\u00a0C, D\u00e9pret\u00a0F, Soussi\u00a0S et al (2019) Contributing factors and outcomes of burn-associated cholestasis. J\u00a0Hepatol 5:1\u201311","journal-title":"J Hepatol"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/ALN.0b013e318266c6df","volume":"117","author":"T Lescot","year":"2012","unstructured":"Lescot\u00a0T, Karvellas\u00a0C, Beaussier\u00a0M, Magder\u00a0S (2012) Acquired liver injury in the intensive care unit. Anesthesiology 117:898\u2013904","journal-title":"Anesthesiology"},{"key":"618_CR12","first-page":"263","volume":"4","author":"N Waseem","year":"2016","unstructured":"Waseem\u00a0N, Chen\u00a0P (2016) Hypoxic hepatitis: a review and clinical update. J\u00a0Clin Transl Hepatol 4:263\u2013268","journal-title":"J Clin Transl Hepatol"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"J Cordoba","year":"2017","unstructured":"Cordoba\u00a0J, Dhawan\u00a0A, Larsen\u00a0F et\u00a0al (2017) EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J\u00a0Hepatol 66:1047\u20131081","journal-title":"J Hepatol"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00063-013-0320-5","volume":"109","author":"A Drolz","year":"2014","unstructured":"Drolz\u00a0A, Horvatits\u00a0T, Roedl\u00a0K, Fuhrmann\u00a0V (2014) Shock liver and cholestatic liver in critically ill patients. Med Klin Intensivmed Notfmed 109:228\u2013234","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2169\/internalmedicine.46.0059","volume":"46","author":"R Birrer","year":"2007","unstructured":"Birrer\u00a0R, Takuda\u00a0Y, Takara\u00a0T (2007) Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 46:1063\u20131070","journal-title":"Intern Med"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4291\/wjgp.v8.i3.108","volume":"8","author":"R Shah","year":"2017","unstructured":"Shah\u00a0R, Taborda\u00a0C, Chawla\u00a0S (2017) Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. World J Gastrointest Pathophysiol 8:108\u2013116","journal-title":"World J Gastrointest Pathophysiol"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.ajem.2015.05.008","volume":"22","author":"S Oh","year":"2015","unstructured":"Oh\u00a0S, Kim\u00a0H, Park\u00a0K et al (2015) Hypoxic hepatitis in survivors of out-of-hospital cardiac arrest. Am J Emerg Med 22:1166\u20131170","journal-title":"Am J Emerg Med"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00392-016-1060-3","volume":"106","author":"C Jung","year":"2016","unstructured":"Jung\u00a0C, Fuernau\u00a0G, Eitel\u00a0I et\u00a0al (2016) Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol 106:341\u2013349","journal-title":"Clin Res Cardiol"},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/TCRM.S59312","volume":"10","author":"N Chavez-Tapia","year":"2014","unstructured":"Chavez-Tapia\u00a0N, Meza-Meneses\u00a0P, Balderas-Garces\u00a0B et al (2014) Hypoxic hepatitis in cardiac intensive care unit: a\u00a0study of cardiovascular risk factors, clinical course, andoutcomes. Ther Clin Risk Manag 10:139\u2013145","journal-title":"Ther Clin Risk Manag"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s00134-011-2248-7","volume":"37","author":"V Fuhrmann","year":"2011","unstructured":"Fuhrmann\u00a0V, Kneidinger\u00a0N, Herkner\u00a0H et\u00a0al (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302\u20131310","journal-title":"Intensive Care Med"},{"key":"618_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.23736\/S0375-9393.16.11442-7","volume":"83","author":"A Blandino Ortiz","year":"2017","unstructured":"Blandino Ortiz\u00a0A, Lamanna\u00a0I, Antonucci\u00a0E et al (2017) Altered liver function in patients undergoing veno-arterial extracorporeal membrane oxygenation (ECMO) therapy. Minerva Anestesiol 83:255\u2013265","journal-title":"Minerva Anestesiol"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.26574\/maedica.2018.13.1.5","volume":"13","author":"A Ciobanu","year":"2018","unstructured":"Ciobanu\u00a0A, Gherasim\u00a0L (2018) Ischemic Hepatitis\u2014Intercorrelated Pathology. Maedica 13:5\u201311","journal-title":"Maedica"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1521-6918(03)00025-8","volume":"17","author":"C Strassburg","year":"2003","unstructured":"Strassburg\u00a0C (2003) Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol 17:369\u2013381","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s10620-014-3106-6","volume":"59","author":"M Romero","year":"2014","unstructured":"Romero\u00a0M, Palmer\u00a0S, Kahn\u00a0J et\u00a0al (2014) Imaging appearance in acute liver failure: correlation with clinical and pathology findings. Dig Dis Sci 59:1987\u20131995","journal-title":"Dig Dis Sci"},{"key":"618_CR25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/2047-783X-14-12-541","volume":"14","author":"F Saner","year":"2009","unstructured":"Saner\u00a0F, Heuer\u00a0M, Meyer\u00a0M et\u00a0al (2009) When the heart kills the liver: acute liver failure in congestive heart failure. Eur J Med Res 14:541\u2013546","journal-title":"Eur J Med Res"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/eurheartj\/ehv051","volume":"36","author":"H Thiele","year":"2015","unstructured":"Thiele\u00a0H, Ohman\u00a0E, Desch\u00a0S et\u00a0al (2015) Management of cardiogenic shock. Eur Hear\u00a0J 36:1223\u20131230","journal-title":"Eur Hear J"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MCC.0b013e3283374b1c","volume":"16","author":"S Jakob","year":"2010","unstructured":"Jakob\u00a0S (2010) The effects of mechanical ventilation on hepato-splanchnic perfusion. Curr Opin Crit Care 16:165\u2013168","journal-title":"Curr Opin Crit Care"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/lt.24461","volume":"22","author":"F Tacke","year":"2016","unstructured":"Tacke\u00a0F, Kroy\u00a0D, Barreiros\u00a0A, Neumann\u00a0U (2016) Liver transplantation in Germany. Liver Transpl 22:1136\u20131142","journal-title":"Liver Transpl"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12871-018-0538-0","volume":"18","author":"M Buechter","year":"2018","unstructured":"Buechter\u00a0M, Gerken\u00a0G, Hoyer\u00a0D et\u00a0al (2018) Liver maximum capacity (LiMAx) test as a\u00a0helpful prognostic tool in acute liver failure with sepsis: a\u00a0case report. BMC Anesthesiol 18:1\u20138","journal-title":"BMC Anesthesiol"},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"R266","DOI":"10.1186\/cc10543","volume":"15","author":"A Koch","year":"2011","unstructured":"Koch\u00a0A, Horn\u00a0A, D\u00fcckers\u00a0H et al (2011) Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a\u00a0medical ICU. Crit Care 15:R266","journal-title":"Crit Care"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-00618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-019-00618-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-00618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T01:07:16Z","timestamp":1664413636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-019-00618-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s00063-019-00618-6","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,19]]},"assertion":[{"value":"30 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>P.\u00a0Kasper<\/b>: A.\u00a0Finanzielle Interessen: P.\u00a0Kasper gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt, Klinik f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum K\u00f6ln, K\u00f6ln. <b>F.\u00a0Tacke<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Allergan, Bristol-Myers Squibb, Galapagos, Inventiva. \u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AbbVie, Gilead, Falk, MSD. \u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Allergan, Bayer, Bristol-Myers Squibb, Pfizer, Abbott, Inventiva, Ipsen. \u2013 B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Medizinische Klinik m.\u202fS. Hepatologie und Gastroenterologie | Vorstand, Europ\u00e4ische Lebergesellschaft (EASL) | Leitlinienmitarbeit Deutsche Gesellschaft f\u00fcr Gastroenterologie (DGVS). <b>H.-M.\u00a0Steffen<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Firmen: Pfizer, Novartis, Bristol-Myers Squibb, Gr\u00fcnenthal | Deutsche Hypertonie Akademie. \u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Mitgestaltung internetbasierter Informationen f\u00fcr Patienten mit CED der Fa. Pfizer GmbH. \u2013 B.\u00a0Nichtfinanzielle Interessen: Arzt f\u00fcr innere Medizin \u2013 Gastroenterologe und Kardiologe, ESH Clinical Hypertension Specialist \u2013 DHL Hypertensiologe | zuletzt Oberarzt an der Klinik f\u00fcr Gastroenterologie und Hepatologie, Universit\u00e4tsklinikum K\u00f6ln | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin, Deutsche Gesellschaft f\u00fcr Herz- und Kreislaufforschung, European Society of Cardiology, European Society of Hypertension, Deutsche Hochdruckliga e.\u202fV. \u2013 Deutsche Gesellschaft f\u00fcr Hypertonie und Pr\u00e4vention, Deutsche Gesellschaft f\u00fcr Verdauungs- und Stoffwechselkrankheiten, Deutsche Tropenmedizinische Gesellschaft. <b>G.\u00a0Michels<\/b>: A.\u00a0Finanzielle Interessen: Honorare f\u00fcr Vortragst\u00e4tigkeiten von Fa. Pfizer, Fa. Novartis, Fa. Servier, Fa. Zoll, Fa. Getinge, Fa. Sedana Medical Deutschland und Fa. Orion Pharma. Die Interessenkonflikte stehen in keinem Zusammenhang mit dem vorliegenden Artikel. \u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Oberarzt, Klinik\u00a0III f\u00fcr Innere Medizin \u2013 Kardiologie, Pneumologie, Angiologie und internistische Intensivmedizin, Uniklinik K\u00f6ln, K\u00f6ln | Mitgliedschaften: Wissenschaftlicher Beirat der Deutschen Gesellschaft f\u00fcr Internistische Intensivmedizin und Notfallmedizin e.\u202fV. (DGIIN), Wissenschaftlicher Beirat der Deutschen Herzstiftung, Arbeitsgruppe ECMO\/eCPR des Deutschen Rats f\u00fcr Wiederbelebung e.\u202fV. (German Resuscitation Council, GRC), Sektion Ethik der DGIIN, Deutsche Interdisziplin\u00e4re Vereinigung f\u00fcr Intensiv- und Notfallmedizin e.\u202fV. (DIVI) | Sprecher der Arbeitsgruppe Kardiopulmonale Reanimation (AG42) der Deutschen Gesellschaft f\u00fcr Kardiologie e.\u202fV. (DGK).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}